ClinicalTrials.Veeva

Menu

Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Glaucoma
AMD

Treatments

Procedure: Optical Coherence Tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT01766596
Creuzot-Garcher PHRC IR 2009

Details and patient eligibility

About

The aim of the study proposed in Dijon is above all to focus on the possible relationship between age-related ocular pathologies (AMD and glaucoma) and et les degenerative neurological and cardiac pathologies.

The principal objective is to seek in subjects who have undergone cerebral MRI and echocardiography, associations between the thickness of postganglionic fibers measured by Optical Coherence Tomography at the 7th year (n=1500) and signs of cerebral impairment (psycho-cognitive tests, circulation time, MRI signs). This association will be studied after taking into account the principal environmental (particularly dietary) and genetic risk factors.

Enrollment

1,153 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Persons who have given their written consent
  • Persons who are taking part in the Dijon 3C study

Exclusion criteria

  • Persons who are not registered with social security agency
  • Persons who are unable to sit upright during a consultation

Trial design

1,153 participants in 1 patient group

3C cohort
Other group
Treatment:
Procedure: Optical Coherence Tomography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems